Morris, S. J. (Susan J.) and Leppard, Keith. (2009) Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. Journal of Virology, Vol.83 (No.7). pp. 3049-3058. ISSN 0022-538X

Preview

PDF WRAP_Leppard_8770156-090709-morris_and_leppard-revised.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (576Kb)

Abstract

Adenoviruses express up to 20 distinct mRNAs from five major late transcription unit (MLTU) regions, L1 to L5, by differential splicing and polyadenylation of the primary transcript. MLTU expression is regulated at transcriptional and posttranscriptional levels. The L4-33K protein acts as a splicing factor to upregulate several MLTU splice acceptor sites as the late phase progresses. The L4 region also expresses a 22K protein whose sequence is related to the sequence of L4-33K. L4-22K is shown here also to have an important role in regulating the pattern of MLTU gene expression. An adenovirus genome containing a stop codon in the L4-22K open reading frame expressed low levels of both structural and nonstructural late proteins compared to the wild-type (wt) adenovirus genome; a decrease in intermediate proteins, IVa2 and IX, was also observed. However, early protein synthesis and replication were unaffected by the absence of L4-22K. Intermediate and late protein expression was restored to wt levels by L4-22K expressed in trans but not by L4-33K. Increased MLTU promoter activity, resulting from stabilization of the transcriptional activator IVa2 by L4-22K, made a small contribution to this restoration of late gene expression. However, the principal effect of L4-22K was on the processing of MLTU RNA into specific cytoplasmic mRNA. L4-22K selectively increased expression of penton mRNA and protein, whereas splicing to create penton mRNA is known not to be increased by L4-33K. These results indicate that L4-22K plays a key role in the early-late switch in MLTU expression, additional to and distinct from the role of L4-33K.

Item Type:	Journal Article
Subjects:	Q Science > QR Microbiology > QR355 Virology
Divisions:	Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH):	Adenoviruses, Viral genetics, Serology, Proteins -- Synthesis, Messenger RNA
Journal or Publication Title:	Journal of Virology
Publisher:	American Society for Microbiology
ISSN:	0022-538X
Date:	April 2009
Volume:	Vol.83
Number:	No.7
Page Range:	pp. 3049-3058
Identification Number:	10.1128/JVI.02455-08
Status:	Peer Reviewed
Access rights to Published version:	Open Access
Funder:	Biotechnology and Biological Sciences Research Council (Great Britain) (BBSRC)
Grant number:	BB/E014550/1 (BBSRC)
References:	# Akusjarvi, G. 2008. Temporal regulation of adenovirus major late alternative RNA splicing. Frontiers Biosci. 13:5006-5015. # 2 Ali, H., G. LeRoy, G. Bridge, and S. J. Flint. 2007. The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription. J. Virol. 81:1327-1338. # 3 Arslanoglu, A. 1999. Studies of adenovirus L1 gene aimed at L1 gene deficiencies for use in gene therapy vectors. Ph.D. thesis. University of Warwick, Coventry, United Kingdom. # 4 Brey, S. 1999. Construction of IVa2-deficient adenovirus using complementing cell lines. Ph.D. thesis, University of Warwick, Coventry, United Kingdom. # 5 Caravokyri, C., and K. N. Leppard. 1995. Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J. Virol. 69:6627-6633. # 6 Cepko, C. L., and P. A. Sharp. 1982. Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell 31:407-415. # 7 Chang, L. S., and T. Shenk. 1990. The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters. J. Virol. 64:2103-2109. # 8 Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810. # 9 Chen, H., R. Vinnakota, and S. J. Flint. 1994. Intragenic activating and repressing elements control transcription from the adenovirus IVa2 initiator. Mol. Cell. Biol. 14:676-685. # 10 Crossland, L. D., and H. J. Raskas. 1983. Identification of adenovirus genes that require template replication for expression. J. Virol. 46:737-748. # 11 Davison, A. J., M. Benko, and B. Harrach. 2003. Genetic content and evolution of adenoviruses. J. Gen. Virol. 84:2895-2908.[Abstract/Free Full Text] # 12 Farley, D. C., J. L. Brown, and K. N. Leppard. 2004. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J. Virol. 78:1782-1791. # 13 Fessler, S. P., and C. S. H. Young. 1999. The role of the L4 33K gene in adenovirus infection. Virology 263:507-516. # 14 Finnen, R. L., J. F. Biddle, and J. Flint. 2001. Truncation of the human adenovirus type 5 L4 33-kDa protein: evidence for an essential role of the carboxy-terminus in the viral infectious cycle. Virology 289:388-399. # 15 Gustin, K. E., P. Lutz, and M. J. Imperiale. 1996. Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection. J. Virol. 70:6463-6467. # 16 Hardy, S., M. Kitamura, T. Harris-Stansil, Y. Dai, and M. L. Phipps. 1997. Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71:1842-1849. # 17 Hayes, B. W., G. C. Telling, M. M. Myat, J. F. Williams, and S. J. Flint. 1990. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64:2732-2742. # 18 Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369. # 19 Iftode, C., and S. J. Flint. 2004. Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene. Proc. Natl. Acad. Sci. USA 101:17831-17836. # 20 Jansen-Durr, P., G. Mondesert, and C. Kedinger. 1989. Replication-dependent activation of the adenovirus major late promoter is mediated by the increased binding of a transcription factor to sequences in the first intron. J. Virol. 63:5124-5132. # 21 Jones, N., and T. Shenk. 1978. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181-188. # 22 Larsson, S., C. Svensson, and G. Akusjarvi. 1992. Control of adenovirus major late gene expression at multiple levels. J. Mol. Biol. 225:287-298. # 23 Lethbridge, K. J., G. E. Scott, and K. N. Leppard. 2003. Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein. J. Gen. Virol. 84:259-268. # 24 Lin, H. J., and S. J. Flint. 2000. Identification of a cellular repressor of transcription of the adenoviral late IVa(2) gene that is unaltered in activity in infected cells. Virology 277:397-410. # 25 Lutz, P., and C. Kedinger. 1996. Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter. J. Virol. 70:1396-1405. # 26 Lutz, P., M. Rosa-Calatrava, and C. Kedinger. 1997. The product of the adenovirus intermediate gene IX is a transcriptional activator. J. Virol. 71:5102-5109. # 27 Michou, A. I., L. Santoro, M. Christ, V. Julliard, A. Pavirani, and M. Mehtali. 1997. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4:473-482. # 28 Mondesert, G., C. Tribouley, and C. Kedinger. 1992. Identification of a novel downstream binding protein implicated in late-phase-specific activation of the adenovirus major late promoter. Nucleic Acids Res. 20:3881-3889. # 29 Morris, S. J., H. Smith, and C. Sweet. 2002. Exploitation of the herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role. Arch. Virol. 147:961-979. # 30 Nevins, J. R., and M. C. Wilson. 1981. Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature 290:113-118. # 31 Ostapchuk, P., M. E. Anderson, S. Chandrasekhar, and P. Hearing. 2006. The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. J. Virol. 80:6973-6981. # 32 Pardo-Mateos, A., and C. S. Young. 2004. Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo. Virology 327:50-59. # 33 Philipson, L. 1961. Adenovirus assay by the fluorescent cell-counting procedure. Virology 15:263-268. # 34 Reich, N. C., P. Sarnow, E. Duprey, and A. J. Levine. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128:480-484. # 35 Russell, W. C. 2000. Update on adenovirus and its vectors. J. Gen. Virol. 81:2573-2604. # 36 Russell, W. C., G. Patel, B. Precious, I. Sharp, and P. S. Gardner. 1981. Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization. J. Gen. Virol. 56:393-408. # 37 Soloway, P. D., and T. Shenk. 1990. The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs. J. Virol. 64:551-558. # 38 Symington, J. S., L. A. Lucher, K. H. Brackmann, A. Virtanen, U. Pettersson, and M. Green. 1986. Biosynthesis of adenovirus type 2 i-leader protein. J. Virol. 57:848-856. # 39 Tormanen, H., E. Backstrom, A. Carlsson, and G. Akusjarvi. 2006. L4-33K, an adenovirus-encoded alternative RNA splicing factor. J. Biol. Chem. 281:36510-36517. # 40 Tribouley, C., P. Lutz, A. Staub, and C. Kedinger. 1994. The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter. J. Virol. 68:4450-4457. # 41 Yang, J., T. Tsukamoto, N. Popnikolov, R. C. Guzman, X. Chen, J. H. Yang, and S. Nandi. 1995. Adenoviral-mediated gene transfer into primary human and mouse mammary epithelial cells in vitro and in vivo. Cancer Lett. 98:9-17. # 42 Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442. # 43 Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411. # 44 Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216. # 45 Zhang, W., and M. J. Imperiale. 2000. Interaction of the adenovirus IVa2 protein with viral packaging sequences. J. Virol. 74:2687-2693. # 46 Zhang, W., J. A. Low, J. B. Christensen, and M. J. Imperiale. 2001. Role for the adenovirus IVa2 protein in packaging of viral DNA. J. Virol. 75:10446-10454.
URI:	http://wrap.warwick.ac.uk/id/eprint/1060

Request changes to a record

Actions (login required)

View Item